Press Releases
Search
-
25 Sep 2008
bioMérieux to Develop New Highly-Specific, Non-invasive Test for Prostate Cancer, Reducing Unnecessary Biopsies
Marcy l'Etoile, France - September 25, 2008. Prostate cancer is the most prevalent cancer in the United States and the 4th most common worldwide. The combination of a test for a new prostate cancer bi...
-
11 Sep 2008
bioMérieux Gains Critical Oncology and Theranostics Capabilities with the Acquisition of Molecular Diagnostics Company AviaraDx
Marcy l'Etoile, France - September 11, 2008. bioMérieux, a world leader in the field of in vitro diagnostics has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, b...
-
08 Sep 2008
First-Half 2008 Financial Report Sustained sales growth while consolidating profitability - Operating income before non-recurring items up 7.6%
Marcy l'Etoile, France - September 8, 2008. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its interim financial report for the first six months of 20...
-
01 Sep 2008
Steve Harbin's appointment
September 1, 2008. A world leader in the field of in vitro diagnostics, bioMérieux has appointed Steve Harbin as Corporate Vice President, Quality Management Systems, Health, Safety and Environment an...
-
23 Jul 2008
bioMérieux - First-Half 2008 Review
Marcy l'Etoile, France - July 23, 2008. bioMérieux, a global leader in the field of in vitro diagnostics, today released its interim review for the six months ended June 30, 2008.
-
18 Jun 2008
bioMérieux Increases its Lead in Microbiology with the Acquisition of the Swedish Diagnostics Specialist AB BIODISK. Company’s Etest® will enhance bioMérieux’s high medical-value offer
June 18, 2008 . bioMérieux, a world leader in the field of in vitro diagnostics has concluded an agreement to acquire the privately held AB BIODISK, a Swedish in vitro diagnostics company with facilit...